A Patient with 38 Years of Smoking History and Severe Shortness of Breath
https://doi.org/10.22416/1382-4376-2023-33-5-105-113
Abstract
Aim: to present a clinical case of post-COVID bronchiolitis in an adult.
Key points. A 54-year-old female patient with a long history of smoking was hospitalized in the pulmonology department of the Clinic with a leading complaint of progressive shortness of breath after a COVID-19 infection. The diagnosis was established: bilateral bronchiolitis associated with a new coronavirus infection (SARS-CoV-2 polymerase chain reaction — positive); chronic obstructive pulmonary disease stage II according to GOLD (Global Initiative for Chronic Obstructive Lung Disease), exacerbation. Against the background of the therapy, there was a significant positive dynamics in well-being and in CT-picture of bronchiolitis. The patient was discharged for outpatient follow-up treatment. One of the most common symptoms of post-COVID syndrome is shortness of breath. Diagnosis of bronchiolitis, in which this symptom may be the only one, is difficult, especially in patients with a long history of smoking and the presence of comorbid pulmonary pathology.
Conclusion. A clinical case of bilateral bronchiolitis in the framework of the post-COVID syndrome is presented. The key to successful diagnosis of bronchiolitis is a thorough differential analysis of the totality of anamnestic and clinical laboratory data, as well as a characteristic CT pattern.
About the Authors
E. R. Buklis
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Elvira R. Buklis — Cand Sci. (Med.), Physician, Department of Pulmonology, V.Kh. Vasilenko Clinic of Internal Disease Propaedeutics, Gastroenterology and Hepatology
119435, Moscow, Pogodinskaya str., 1, build. 1
N. I. Kokina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Natalia I. Kokina — Cand. Sci. (Med.), Associate Professor of the Department of Internal Disease Propaedeutics, Departmental Head, Pulmonology Department, V.Kh. Vasilenko Clinic of for Propaedeutics of Internal Diseases, Gastroenterology and Hepatology
119435, Moscow, Pogodinskaya str., 1, build. 1
E. L. Bueverova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Elena L. Bueverova — Cand. Sci. (Med.), Associate Professor of the Department of Internal Disease Propaedeutics, Gastroenterology and Hepatology, N.V. Sklifosovsky Institute of Clinical Medicine
119435, Moscow, Pogodinskaya str., 1, build. 1
M. V. Feldsherov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Mikhail V. Feldsherov — Cand. Sci. (Med.), Head of the Department of Radiation Diagnostics, University Clinical Hospital No. 2
119435, Moscow, Pogodinskaya str., 1, build. 1
V. S. Komarova
Polyclinic No. 7 of the Federal Security Service of the Russian Federation
Russian Federation
Russian Federation
Valeriia S. Komarova — Physician
127018, Moscow, Oktyabrskaya str., 49, bld. 1
V. T. Ivashkin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Vladimir T. Ivashkin — Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences, Head of the Department of Propaedeutics of Internal Diseases, Gastroenterology and Hepatology, Director of V.Kh. Vasilenko Clinic of Internal Diseases Propedeutics, Gastroenterology and Hepatology
119435, Moscow, Pogodinskaya str., 1, build. 1
References
1. World Health Organization. Novel coronavirus (2019- nCoV) situation report 5. 25 January 2020 URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200125-sitrep-5-2019-ncov.pdf?sfvrsn=429b143d_8
2. Lenharo M. WHO declares end to COVID-19’s emergency phase. Nature. 2023 May 5. (Online ahead of print). DOI: 10.1038/d41586-023-01559-z
3. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19): Temporary guidelines. Version 17, approved by the Ministry of Health of the Russian Federation December 14 2022. (In Russ.). URL: rosminzdrav. ru/ministry/med_covid19
4. World Health Organization. Coronavirus (COVID-19) Dashboard. Russian Federation. URL: https://covid19.who.int/region/euro/country/ru
5. Ivaschkin V.T., Zolnikova О.Yu., Svistunov A.A., Kokina N.I., Dzhakhaya N.L., Potskhverashvili N.D., et al. Corticosteroids in the treatment of SARS-CoV-2 related lung disease. Sechenov Medical Journal. 2020;11(2):19– 28. (In Russ.). DOI: 10.47093/2218-7332.2020.11.2.19-28
6. Global strategy for the diagnosis, treatment and prevention of chronic obstructive pulmonary disease (revision of 2014). Moscow: Russian Respiratory Society, 2014. (In Russ.).
7. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. October 6, 2021. URL: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
8. Abdel-Gawad M., Zaghloul M.S., Abd-Elsalam S., Hashem M., Lashen S.A., Mahros A.M., et al. Post-COVID-19 syndrome clinical manifestations: A systematic review. Antiinflamm Antiallergy Agents Med Chem. 2022;21(2):115–20. DOI: 10.2174/1871523021666220328115818
9. Torres-Castro R., Vasconcello-Castillo L., Alsina-Restoy X., Solis-Navarro L., Burgos F., Puppo H., et al. Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis. Pulmonology. 2021;27(4):328– 37. DOI: 10.1016/j.pulmoe.2020.10.013
10. Zhao Y.M., Shang Y.M., Song W.B., Li Q.Q., Xie H., Xu Q.F., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. DOI: 10.1016/j.eclinm.2020.100463
11. Sebina I., Phipps S. The contribution of neutrophils to the pathogenesis of RSV bronchiolitis. Viruses. 2020;12(8):808. DOI: 10.3390/v12080808
12. van der Hoek L., Pyrc K., Jebbink M., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C., et al. Identification of a new human coronavirus. Nat Med. 2004;10:368–73. DOI: 10.1038/nm1024
13. Arden K.E., Nissen M.D., Sloots T.P., Mackay I.M. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol. 2005;75(3):455–62. DOI: 10.1002/jmv.20288
14. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005;79(2):884–95. DOI: 10.1128/JVI.79.2.884-895.2005
15. Lau S.K., Woo P.C., Yip C.C., Tse H., Tsoi H.W., Cheng V.C., et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol. 2006;44(6):2063–71. DOI: 10.1128/JCM.02614-05
16. Bianchi F., Bennett D., Alderighi L., Pieroni M., Refini R.M., Fossi A., et al. Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female. J Asthma. 2021;58(8):1128– 31. DOI: 10.1080/02770903.2020.1761981
17. Global Burden of Disease Long COVID Collaborators; Wulf Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., et. al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604– 15. DOI: 10.1001/jama.2022.18931
18. Florin T.A., Plint A.C., Zorc J.J. Viral bronchiolitis. Lancet. 2017;389(10065):211–24. DOI: 10.1016/S0140- 6736(16)30951-5
19. Avdeev S.N., Avdeeva O.E. Bronchiolitis of adults. Atmosphere. Pulmonology and Allergology. 2005;2:11–7. (In Russ.).
20. Bolevich S.B., Bolevich S.S. Complex mechanism of COVID-19 development. Sechenov Medical Journal. 2020;11(2):50–61. (In Russ.). DOI: 10.47093/2218-7332.2020.11.2.50-61
21. Risitano A.M., Mastellos D.C., Huber-Lang M., Yancopoulou D., Garlanda C., Ciceri F., et al. Complement as a target in COVID-19? Nat Rev Immunol. 2020;20(6):343– 4. DOI: 10.1038/s41577-020-0320-7
22. Carvelli J., Demaria O., Vély F., Batista L., Chouaki Benmansour N., Fares J., et al.; Explore COVID-19 IPH group; Explore COVID-19 Marseille Immunopole group. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature. 2020;588(7836):146–50. DOI: 10.1038/s41586-020-2600-6
23. Lee N.J., Do K.-H. Many faces of the centrilobular nodules: What should radiologists consider? ECR 2017. Poster number C-1781. DOI: 10.1594/ecr2017/C-1781
24. Karnaushkina M.A., Strutynskaya A.D., Babak S.L., Gorbunova M.V. Characteristics radiologic signs of infectious bronchiolitis. A practical approach for the general doctors. The Russian Archives of Internal Medicine. 2021;11(2):85–93. (In Russ.). DOI: 10.20514/2226-6704-2021-11-2-85-93
25. Berniker A.V., Henry T.S. Imaging of small airway diseases. Radiol Clin North Am. 2016;54(6):1165–81. DOI: 10.1016/j.rcl.2016.05.009
26.
Review
For citations:
Buklis E.R., Kokina N.I., Bueverova E.L., Feldsherov M.V., Komarova V.S., Ivashkin V.T. A Patient with 38 Years of Smoking History and Severe Shortness of Breath. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(5):105-113. https://doi.org/10.22416/1382-4376-2023-33-5-105-113
Views:
507
Email this article 
